Welcome to PERMEPSY
International project dedicated to establishing a personalized approach to psychological treatment for psychosis.
About project
PERMEPSY is a three-year project coordinated by the Parc Sanitari Sant Joan de Déu composed of 5 clinical partners from 5 different countries (Spain, Germany, France, Poland, and Chile) and one technological team (Spain). The aim of PERMEPSY (Personalised Medicine approach to psychological treatment for Psychosis) is to offer personalised delivery of Metacognitive Training (MCT) for people with psychosis.
Research team
Our consortium relies on a multidisciplinary team that includes experts in clinical psychology, psychiatry, computer science and artificial intelligence, molecular biology, and statistics. The clinical partners (coordinators FJSD, and partners UKE, UHS, PAoS, and UV) have collaborated throughout the years to develop MCT strategies addressed to patients with psychosis in different stages of the disorder.
Updates
You will find updates here about our project. If you want to stay up-to-date, join our newsletter.
🔬 PERMEPSY at the #EPPerMed Conference! 🔬
🇩🇪 On February 11-12, EP PerMed – the European Partnership for Personalised Medicine hosted its Conference on “Personalised Medicine Research”, bringing together 250 international experts in
🟢 How can machine learning enhance benefits from MCT for psychosis? 🟢
One of our members, Adrien Goncalves, presented at the 22nd Schizophrenia Days (Journées de la Schizophrénie – PositiveMinders). 🎤 Conference (in French): “When AI steps
📢 New poster from the PERMEPSY group 📢
Merle Schlechte, Rabea Fischer & Steffen Moritz 🇩🇪 present a new study comparing the standard “Metacognitive Training for psychosis” (MCT) program with its personalized version (P-MCT). 🔹 Why? While